Date: Thursday, June 21, 11:30 - 13:00
Location: Eshkol 2 Hall
How will medical clinics look like in the future? How will tomorrow’s hospitals be managed? To what extent will technological breakthroughs in gene research, nanotechnology, stem cells, artificial intelligence, and the increased capacity to collect and analyze large quantities of medical data for each individual improve our health and prolong our lives? Will pharmaceutical remedies be different and will they be tailored personally to each patient? Are new diseases expected to emerge? And how will future doctors be trained?
Professor Hermona Soreq, Israel: Professor, Head, Soreq Research Team, The Edmond and Lily Safra Center for Brain Sciences; former Dean, Faculty of Mathematics and Natural Sciences; former Head, The Eric Roland Center for Neurodegenerative Diseases, The Hebrew University of Jerusalem; Member, UK-Israel Life Sciences Council; Member, Board of Directors, Yissum; Member, Board of Governors, Tel-Hai Academic College. Co-author: STRESS: from molecules to behaviour. A comprehensive analysis of the neurobiology of stress responses (2009), Stressed Out: Towards the Molecular Biology of Stress Responses (2004). Recipient: Israeli Ministry of Health Prize; Landau Prize for Biomedical Research; Teva Prize for Molecular Medicine; Lise Meitner Humboldt Research Prize.
David B. Agus M.D., USA: Director, University of Southern California (USC) Center for Applied Molecular Medicine; Director, USC Westside Cancer Center; Professor of Medicine and Engineering, USC Keck School of Medicine, Vitterbi School of Engineering; Co-Founder, Navigenics, Applied Proteomics. Author: The End of Illness (2012).
Professor Giora Feuerstein, USA: Chief, Medical and Technical Officer, USG DoD DTRA-CB; Adjunct Professor of Translational Science, Department of BioMedical Engineering, Drexel University; former Assistant Vice President, Head, Discovery Translational Medicine, Wyeth/Pfizer Pharmaceutical. Recipient: Prix Galien for innovation in drug discovery; Wyeth President R&D Award for discovery leadership of Coreg/Carvedilol, the first beta-blocker registered for treatment of chronic heart failure.
Dr. Uma Raman Kotagal, USA: Senior Vice President for Safety, Quality and Transformation, Cincinnati Children’s Hospital Medical Center (CCHMC); Executive Director, James M. Anderson Center for Health Systems Excellence, Professor of Pediatrics, Obstetrics and Gynecology, University of Cincinnati; former Director, Pursuing Perfection Initiative, Robert Wood Johnson Foundation, CCHMC ; Senior faculty member, Institute for Healthcare; Chair, Quality Steering Team, Ohio Children’s Hospital Association; Member, Advisory Committee, Toronto Patient Safety Center; Associate Editor, BMJ Quality and Safety; Member, Institute of Medicine.
Dr. William Linton, USA: Chairman and CEO, Promega Corporation; President, BioPharmaceutical Technology Center Institute; Director, Wisconsin Technology Council; Director, Analytical and Life Science Systems Association.
The panel will be simultaneously translated into Hebrew and English.